Jaakko Hyysalo
Papers
1
Total Citations
2
H-Index
1
About
Jaakko Hyysalo is a leading urological researcher whose work centers on improving prostate cancer prognostication and post-treatment surveillance. His primary research areas include the clinical utility of ultrasensitive PSA (usPSA) assays, the prediction of biochemical recurrence (BCR) after radical prostatectomy, and the refinement of risk stratification in prostate cancer management. Hyysalo’s major contribution lies in demonstrating that usPSA levels can serve as a powerful early indicator of disease progression, potentially enabling clinicians to identify patients at high risk for BCR long before conventional PSA thresholds are reached. His landmark study, “The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy,” analyzed data from over 1,800 patients at Turku University Hospital, providing robust evidence that usPSA values can significantly enhance predictive models. This work has already garnered attention, with 2 citations in its first year, and is poised to influence clinical guidelines. Hyysalo’s research bridges the gap between laboratory innovation and bedside practice, offering a more nuanced approach to post-surgical monitoring that could spare many men from unnecessary treatments while catching recurrences earlier. His dedication to evidence-based urology makes him a rising voice in the field.
Research Focus
Key Achievements
Top Papers
- 1